Trials / Terminated
TerminatedNCT00362765
Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
Assessment of Insulin Sensitivity in Type 2 Diabetics Treated With Metformin, Fenofibrate and Their Combination.
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Double-blind, randomized placebo-controlled study in type 2 diabetes and dyslipidemic patients.Patients will be randomized to one of four treatment arms for 16 weeks: placebo, fenofibrate, metformin, or metformin and fenofibrate combination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fenofibrate | 160 mg |
| DRUG | Metformin | 2000 mg |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2006-10-01
- Completion
- 2007-07-01
- First posted
- 2006-08-10
- Last updated
- 2008-08-13
Locations
3 sites across 3 countries: Finland, Ireland, Italy
Source: ClinicalTrials.gov record NCT00362765. Inclusion in this directory is not an endorsement.